SyntheticMR

SyntheticMR SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI).

SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from one 5-6 minutes scan.

📣We're looking forward to joining MID-INDSPNCON 2026, held in conjunction with the ISPN Education Course 2026, from 24–2...
22/07/2026

📣We're looking forward to joining MID-INDSPNCON 2026, held in conjunction with the ISPN Education Course 2026, from 24–26 July at AIIMS, New Delhi.

During the meeting, we'll be discussing how SyMRI® and cMRI® are helping advance brain MRI through quantitative imaging, AI-powered clinical decision support, and objective tissue assessment.

If you're attending, we'd love to connect and discuss how quantitative MRI can support clinical practice and research. Stop by for a conversation or get in touch to arrange a meeting during the event.

See you in New Delhi!

🤝Support the dementia care pathway, from assessment and diagnosis to treatment monitoring and follow-up, with one integr...
02/07/2026

🤝Support the dementia care pathway, from assessment and diagnosis to treatment monitoring and follow-up, with one integrated platform.

• MRI quantification, including ARIA monitoring
• Web-based cognitive assessment
• AI-powered decision support
• FDG PET, Amyloid PET and DaTSCAN quantification, including Centiloid for PET

📢 Join us at , Booth 109, and discover how cNEURO brings these capabilities together in a single platform.

Book a meeting with our team in advance or visit us at Booth 109 to experience cNEURO firsthand. https://calendly.com/syntheticmr/syntheticmr-combinostics-aaic2026?month=2026-07

See you in London.

📢 Join us at  , Booth 109, and discover how cNEURO supports the dementia care pathway, from assessment and diagnosis to ...
24/06/2026

📢 Join us at , Booth 109, and discover how cNEURO supports the dementia care pathway, from assessment and diagnosis to treatment monitoring and follow-up.

Experience cNEURO firsthand:

• MRI quantification, including ARIA monitoring
• Web-based cognitive assessment
• AI-powered decision support
• FDG PET, Amyloid PET and DaTSCAN quantification, including Centiloid for PET

See you in London.

15/06/2026

🧠 June is Alzheimer's & Brain Awareness Month.

More than 57 million people worldwide are living with dementia, and Alzheimer's disease is the most common cause. With dementia cases expected to nearly triple by 2050, raising awareness and promoting early detection has never been more important.

Early detection is critical. Recognizing the signs sooner can help ensure patients receive the right care, support, and treatment at the right time.

Together, we can continue raising awareness, supporting earlier diagnosis, and improving outcomes for those impacted by Alzheimer's disease.

How is quantitative MRI (qMRI) moving from research into everyday clinical practice?Priv.-Doz. DDr. Victor Schmidbauer s...
01/06/2026

How is quantitative MRI (qMRI) moving from research into everyday clinical practice?

Priv.-Doz. DDr. Victor Schmidbauer shares how SyMRI is being applied to support more efficient diagnostic workflows and advanced neuroimaging analysis.

As a leading Research Associate at the Department of Biomedical Imaging and Image-Guided Therapy, Dr. Schmidbauer discusses the evolving role of quantitative MRI, synthetic imaging, and automated post-processing in clinical decision-making and patient care.

Key topics include:

• Clinical applications of SyMRI
• Quantitative MRI in routine practice
• Workflow efficiency and diagnostic support
• The future of advanced neuroimaging

Watch now! https://m.youtube.com/watch?v=AhphOFv81Zw&ra=m

What changes when AI and quantitative MRI become part of your daily neuroimaging workflow?In our webinar series Inside M...
26/05/2026

What changes when AI and quantitative MRI become part of your daily neuroimaging workflow?

In our webinar series Inside Modern Neuroimaging: The Untold Clinical Insights, leading experts from top European centers share how quantitative MRI and AI are supporting real clinical decision-making in everyday practice.

🧠 Featured clinical experts:

• Priv.-Doz. DDr. Victor Schmidbauer, AKH Vienna, Austria.
• Prof. Tobias Granberg, Karolinska University Hospital, Stockholm, Sweden.
• Prof. Dr. Dr. Brendel, LMU Hospital Munich, Germany.

If you missed the live sessions, you can now watch the recordings on demand.

👉 Access the webinar series: https://syntheticmr.com/resources/videos/

🧠 In the opening session of our webinar series, we’re diving into two of our own innovative solutions, SyMRI and cNeuro,...
13/04/2026

🧠 In the opening session of our webinar series, we’re diving into two of our own innovative solutions, SyMRI and cNeuro, that are already transforming clinical practice.

🔹 Erik Lange will show how SyMRI can speed up MRI scans while delivering detailed brain tissue insights, helping increase efficiency and support more confident clinical decisions.

🔹 Dr. Elena Bonke will introduce our cNeuro portfolio (cMRI, cDSI, cPET, and cDAT), an automated analysis solution designed to support neuroradiologists, neurologists, and nuclear medicine specialists in their daily work.

📅 April 28
🕓 4:00 PM CEST (UTC+2)
👉 Register here: https://lnkd.in/dtiZZep3

📢 SyntheticMR Annual Report 2025 PublishedOur Annual Report for 2025 is now available. Explore key developments from the...
09/04/2026

📢 SyntheticMR Annual Report 2025 Published

Our Annual Report for 2025 is now available. Explore key developments from the past year, our operational focus, and our long-term strategic priorities.

Read the full report on our website: https://syntheticmr.com/investors/

At Hiroshima University Hospital, SyMRI is used in both research and routine clinical care.It supports the assessment of...
30/03/2026

At Hiroshima University Hospital, SyMRI is used in both research and routine clinical care.
It supports the assessment of patients with neurodegenerative and demyelinating diseases, including ALS, stroke, MS, and dementia.

👉 Discover how it’s used in practice, read the full case study from Hiroshima University Hospital.
https://loom.ly/o_-wT48

3D Synthetic MRI continues to prove its value in clinical neuroimaging. A multicenter study published in AJNR shows that...
23/03/2026

3D Synthetic MRI continues to prove its value in clinical neuroimaging. A multicenter study published in AJNR shows that SyMRI with 3D-QALAS delivers:

✅ Comparable diagnostic performance to conventional MRI
✅ Higher reader-rated image quality

A strong validation of efficient, quantitative imaging in routine workflows where quality and consistency matter more than ever.

📄 Read the publication: https://loom.ly/-FgsG74

Adress

Storgatan 11
Linköping
58223

Aviseringar

Var den första att veta och låt oss skicka ett mail när SyntheticMR postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Affären

Skicka ett meddelande till SyntheticMR:

Genvägar

Dela